FR Q1 2026 Earnings Massive EPS Beat Surprises Market OCUL Q1 2026 Earnings WiderThanExpected Loss as Ocular Therapeutix Advances Pipeline AIT Q1 2026 Earnings EPS Misses Estimates by a Slim Margin Stock Edges Higher Tapestry Inc TPR Q1 2026 Earnings EPS Surges Past Estimates with 26 Surprise BGMS Q3 2024 Earnings Significant EPS Beat Tempered by Revenue Uncertainty Actinium Pharmaceuticals ATNM Q1 2026 Earnings NarrowerThanExpected Loss as Pipeline Advances Continue